SIFCO Industries (NYSEAM) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
5 Oct, 2026Executive summary
Q3 FY2025 net sales were $22.095M versus $21.986M; continuing-operations income was $3.302M versus a $0.917M loss, including a $2.7M net Employee Retention Credit benefit.
Nine-month net sales rose to $62.005M from $57.975M, while the continuing-operations loss narrowed to $0.442M from $7.219M.
Operations focus on domestic aerospace forging after the October 2024 sale of European operations; backlog was $130.4M at June 30, 2025.
Financial highlights
Q3 gross profit was $5.895M versus $2.712M; operating profit was $4.830M versus an operating loss of $0.391M.
Q3 net income was $3.408M versus $0.072M; diluted EPS was $0.56 versus $0.01. Continuing-operations diluted EPS was $0.54 versus a $0.16 loss per share.
Nine-month gross profit was $8.393M versus $3.661M; operating profit was $0.404M versus an operating loss of $3.260M.
Nine-month net loss was $0.300M versus $4.940M; diluted EPS was $(0.05) versus $(0.82).
Discontinued operations recorded a Q3 net loss of $0.1M versus $1.0M income YoY; nine-month income was less than $0.1M versus $2.3M.
Outlook and guidance
Remaining FY2025 capital expenditures are expected to be $0.5M–$1.0M, mainly for production and product capability enhancements and operating cost reductions.
Backlog was $130.4M at June 30, 2025, with $92.5M anticipated to be completed within 12 months; orders may be modified or cancelled with limited charges.
Existing cash and available credit lines are expected to fund operations and planned capital expenditures over the next 12 months; additional debt or equity financing may be sought to support growth plans.
Favorable customer pricing discussions are expected to continue into Q4; a new agreement with Cleveland bargaining unit 2 is anticipated in Q4 FY2025.
Latest events from SIFCO Industries
- FY24 sales rose 20%, with $114.4M backlog driving increased production.NYSEAM
Q4 2024 - Sales rose 6%, continuing losses narrowed, and year-end backlog reached $119.2m.NYSEAM
Q4 2025 - H1 sales rose 10.9%, losses narrowed, and backlog reached $129.2M.NYSEAM
Q2 2025 - Q3 growth lifted earnings, but October debt maturity leaves refinancing risk unresolved.NYSEAM
Q3 2024 - Higher military volumes and pricing drove a sharp return to profit, with financing and environmental risks persisting.NYSEAM
Q2 2026 - Sales rose 35.0%, losses narrowed, and backlog reached $121.9M.NYSEAM
Q1 2025 - Four directors, auditor ratification and a pause in FY2025 long-term awards headline the proxy.NYSEAM
Proxy filing - Military demand lifted nine-month results and backlog, while Q3 earnings absorbed a $3.2 million LIFO impact.NYSEAM
Q3 2026 - Sales rose 14.8% as military demand drove a return to profit and backlog growth.NYSEAM
Q1 2026